Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development

Are you an emerging or small biotech seeking to optimize the early phase development of your small molecule or biologic drug product? Join the webinar recording, available on demand that highlights important regulatory considerations that apply across the global landscape, and help accelerate your initial clinical trials.

In this webinar, our ex-agency expert panel discussed potential early phase challenges and offered strategic solutions to avoid or overcome them. 

What will you learn? 

  • Early-phase CMC strategies for biologics and small molecules
  • Essential non-clinical considerations for first-in-human (FIH) trials
  • Clinical and clinical pharmacology perspectives

Don't miss this opportunity to gain actionable insights that could advance your early phase development strategy and maximize opportunities for regulatory success.

Watch now

Return to Insights Center

Related Insights

Video

Overcoming asset transfer challenges during a merger and acquisition (M&A)

Oct 20, 2021

Blog

Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development

Jan 22, 2025

Article

8 things you need to know about eCTDs in China

Jul 1, 2022

Article

Expedited Pathways Comparisons - US EU CHN

Oct 19, 2021

Blog

Focusing on value drivers to reduce risk in early-stage drug development

Jan 6, 2025

Playbook

What emerging trends in the FDA’s most coveted designations might tell us

Feb 8, 2024

Blog

Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Nov 19, 2021

Article

How a joined-up development strategy pays off for early-stage biotechs

May 19, 2021

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Playbook

Streamlining development in the EU: Strategies for smoother CTA submissions

Feb 27, 2025

Webinar

Accelerated Early Phase Decision-Making – Insider Insights to Speed Development

Jan 7, 2025

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Related Insights

Video

Overcoming asset transfer challenges during a merger and acquisition (M&A)

Oct 20, 2021

Blog

Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development

Jan 22, 2025

Article

8 things you need to know about eCTDs in China

Jul 1, 2022

Article

Expedited Pathways Comparisons - US EU CHN

Oct 19, 2021

Blog

Focusing on value drivers to reduce risk in early-stage drug development

Jan 6, 2025

Playbook

What emerging trends in the FDA’s most coveted designations might tell us

Feb 8, 2024

Show more